Populating an economic model with health state utility values: moving toward better practice
- PMID: 20230546
- DOI: 10.1111/j.1524-4733.2010.00700.x
Populating an economic model with health state utility values: moving toward better practice
Abstract
Background: The methods used to estimate health-state utility values (HSUV) for multiple health conditions can produce very different values. Economic results generated using baselines of perfect health are not comparable with those generated using baselines adjusted to reflect the HSUVs associated with the health condition. Despite this, there is no guidance on the preferred techniques and little research describing the effect on cost per quality adjusted life-year (QALY) results when using the different methods.
Methods: Using a cardiovascular disease (CVD) model and cost per QALY thresholds, we assess the consequence of using different baseline health-state utility profiles (perfect health, no history of CVD, general population) in conjunction with models (minimum, additive, multiplicative) frequently used to approximate scores for health states with multiple health conditions. HSUVs are calculated using the EQ-5D UK preference-based algorithm.
Results: Assuming a baseline of perfect health ignores the natural decline in quality of life associated with age, overestimating the benefits of treatment. The results generated using baselines from the general population are comparable to those obtained using baselines from individuals with no history of CVD. The minimum model biases results in favor of younger-aged cohorts. The additive and multiplicative models give similar results.
Conclusion: Although further research in additional health conditions is required to support our findings, our results highlight the need for analysts to conform to an agreed reference case. We demonstrate that in CVD, if data are not available from individuals without the health condition, HSUVs from the general population provide a reasonable approximation.
Similar articles
-
NICE DSU Technical Support Document 12: The Use of Health State Utility Values in Decision Models [Internet].London: National Institute for Health and Care Excellence (NICE); 2011 Jul. London: National Institute for Health and Care Excellence (NICE); 2011 Jul. PMID: 28481493 Free Books & Documents. Review.
-
Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.Med Care. 2012 May;50(5):452-9. doi: 10.1097/MLR.0b013e318234a04a. Med Care. 2012. PMID: 22002647
-
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8. doi: 10.1016/j.clinthera.2009.12.013. Clin Ther. 2009. PMID: 20110032
-
Using health state utility values in models exploring the cost-effectiveness of health technologies.Value Health. 2012 Sep-Oct;15(6):971-4. doi: 10.1016/j.jval.2012.05.003. Epub 2012 Jun 15. Value Health. 2012. PMID: 22999149 Review.
-
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127. Pediatrics. 2005. PMID: 15867026 Review.
Cited by
-
Cost-Effectiveness Analysis of Gemtuzumab Ozogamicin for First-Line Treatment of Patients with Cd-33 Positive Acute Myeloid Leukaemia in Spain.Clinicoecon Outcomes Res. 2021 Apr 22;13:263-277. doi: 10.2147/CEOR.S302097. eCollection 2021. Clinicoecon Outcomes Res. 2021. PMID: 33911887 Free PMC article.
-
MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis.Health Technol Assess. 2024 Oct;28(61):1-310. doi: 10.3310/PLFG4210. Health Technol Assess. 2024. PMID: 39367754 Free PMC article.
-
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.Health Technol Assess. 2021 Mar;25(21):1-68. doi: 10.3310/hta25210. Health Technol Assess. 2021. PMID: 33764295 Free PMC article.
-
A modelling-based economic evaluation of primary-care-based fall-risk screening followed by fall-prevention intervention: a cohort-based Markov model stratified by older age groups.Age Ageing. 2019 Dec 1;49(1):57-66. doi: 10.1093/ageing/afz125. Age Ageing. 2019. PMID: 31711110 Free PMC article.
-
Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2022 Jan;26(7):1-286. doi: 10.3310/UGEZ4120. Health Technol Assess. 2022. PMID: 35115079 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources